Účinky (fluórfenyl)piperazínového derivátu (látka IIIv) na kardiovaskulárne funkcie Dotaz Zobrazit nápovědu
The present paper links up with the study of principal pharmacological effects of newly synthesized aryloxyaminopropanols substituted with 1,4-piperazine derivatives in the hydrophilic moiety of the molecule. The substance with the working name IIIv showing the highest beta-adrenolytical and vasodilating effect underwent further pharmacological evaluations with the aim of contributing to the elucidation of the mechanism of its action. After 7-day administration of the substance in two doses (5 and 50 mg.kg-1), the changes in the reactibility of arterial preparations were investigated on three models of the contraction of the isolated rat aorta (KCl, noradrenaline, and PGF2 alpha) from both qualitative and quantitative views. The results were also supplemented with organometric studies of the effect of the substance in rats.
- MeSH
- aorta účinky léků fyziologie MeSH
- beta blokátory farmakologie MeSH
- krysa rodu Rattus MeSH
- piperaziny farmakologie MeSH
- potkani Wistar MeSH
- techniky in vitro MeSH
- vazodilatancia farmakologie MeSH
- vazokonstrikce účinky léků MeSH
- vazokonstriktory farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- anglický abstrakt MeSH
- časopisecké články MeSH
- Názvy látek
- beta blokátory MeSH
- piperaziny MeSH
- vazodilatancia MeSH
- vazokonstriktory MeSH